✦ LIBER ✦

Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma

✍ Scribed by Paul Seifert; Laurence H. Baker; Melvin L. Reed; V. K. Vaitkevicius

Publisher: John Wiley and Sons
Year: 1975
Tongue: English
Weight: 391 KB
Volume: 36
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197507)36:1<123::aid-cncr2820360108>3.0.co;2-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9-aminocamptothecin by 72-hour continuou

9-aminocamptothecin by 72-hour continuous intravenous infusion is Inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma

✍ Leonard B. Saltz; Nancy E. Kemeny; William Tong; John Harrison; Regina Berkery; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

thecin, have shown outstanding preclinical activity against colorectal carcinoma. Irinotecan (CPT-11), another camptothecin derivative, has demonstrated clinical

Comparison of 5-fluorouracil with 5-fluo

Comparison of 5-fluorouracil with 5-fluorouracil, cyclophosphamide, and methotrexate in metastatic colorectal carcinoma

✍ Frederick Richards II; Thomas L. Pajak; Miles R. Cooper; Charles L. Spurr 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

Thirty-eight patients with metastatic colorecal carcinoma were treated with 5-fluorouracil (5-FU), and 38 patients were treated with the combination of 5-FU, cyclophosphamide, and methotrexate. In terms of percent response, response duration, and survival there was no apparent difference between the

Bimonthly high dose leucovorin and 5-flu

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma

✍ Karine Beerblock; Yves Rinaldi; Thierry André; Christophe Louvet; Eric Raymond; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

with low dose LV. Based on these reports, a first-line Phase II study was performed in 101 patients with advanced colorectal carcinoma who were given a bimonthly

Comparison of 5-fluorouracil alone, 5-fl

Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma

✍ Robert S. Witte; Avital Cnaan; Edward G. Mansour; Edward Barylak; Jules E. Harri 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

Hepatic chemoembolization combined with

Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma : A Southwest Oncology Group pilot trial

✍ Cynthia Gail Leichman; Joth R. Jacobson; Manuel Modiano; John R. Daniels; Mark M 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

## BACKGROUND. Rates of response to systemic chemotherapy among patients with advanced colorectal carcinoma rarely exceed 25-30%, and complete responses are rare. The liver is the most common site of metastasis; however, regional therapies have not improved survival rates. The Southwest Oncology Gr

A phase II trial of weekly high dose con

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer